polypharmacy

German insurer finds a third of people over 65 take five or more drugs a day.

Stafford N. German insurer finds a third of people over 65 take five or more drugs a day. BMJ. 2013;346:f3905. DOI: 10.1136/bmj.f3905. PubMed PMID: 23771228.

Antipsychotics prescription and cerebrovascular events in Italian older persons.

Franchi C, Sequi M, Tettamanti M, Bonometti F, Nobili A, Fortino I, et al. Antipsychotics prescription and cerebrovascular events in Italian older persons. J Clin Psychopharmacol. 2013;33(4):542-5. DOI: 10.1097/JCP.0b013e3182968fda. PubMed PMID: 23771200.

Individualized medication assessment and planning: optimizing medication use in older adults in the primary care setting.

Roth MT, Ivey JL, Esserman DA, Crisp G, Kurz J, Weinberger M. Individualized medication assessment and planning: optimizing medication use in older adults in the primary care setting. Pharmacotherapy. 2013;33(8):787-97. DOI: 10.1002/phar.1274. PubMed PMID: 23722438.

Polypharmacy in the elderly: a literature review.

Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123-32. DOI: 10.111/j.1041-2972.2005.0020.x. PubMed PMID: 15819637.

Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia.

Glick ID, Pham D, Davis JM. Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia. J Clin Psychiatry. 2006;67(8):1261-5. PubMed PMID: 16965205.

The Medication Reduction Project: combating polypharmacy in South Dakota elders through community-based interventions.

Schrader SL, Dressing B, Blue R, Jensen G, Miller D, Zawada ET. The Medication Reduction Project: combating polypharmacy in South Dakota elders through community-based interventions. S D J Med. 1996;49(12):441-8. PubMed PMID: 8997150.

Treatment with antipsychotics and the risk of diabetes in clinical practice.

Kessing LV, Thomsen AF, Mogensen UB, Andersen PK. Treatment with antipsychotics and the risk of diabetes in clinical practice. Br J Psychiatry. 2010;197(4):266-71. DOI: 10.1192/bjp.bp.109.076935. PubMed PMID: 20884948.

Antipsychotic polypharmacy in schizophrenia: benefits and risks.

Barnes TRE, Paton C. Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs. 2011;25(5):383-99. DOI: 10.2165/11587810-000000000-00000. PubMed PMID: 21476610.

Pharmacotherapy regimens among patients with posttraumatic stress disorder and mild traumatic brain injury.

Morgan M, Lockwood A, Steinke D, Schleenbaker R, Botts S. Pharmacotherapy regimens among patients with posttraumatic stress disorder and mild traumatic brain injury. Psychiatr Serv. 2012;63(2):182-5. DOI: 10.1176/appi.ps.201000531. PubMed PMID: 22302339.

Factors associated with treatment nonadherence among US bipolar disorder patients.

Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol. 2008;23(2):95-105. DOI: 10.1002/hup.908. PubMed PMID: 18058849.